Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere
东半球免疫遗传多样性的演变和功能
基本信息
- 批准号:10365232
- 负责人:
- 金额:$ 79.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-11 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdmixtureAffectAlgorithmsAllelesAsiaAutoimmunityBioinformaticsCRISPR/Cas technologyCell physiologyCellsCharacteristicsChronicChronic DiseaseCommunicable DiseasesComplexCountryDataDevelopmentDiseaseDisease susceptibilityDonor personEnvironmentEvolutionFar EastGenesGeneticGenetic PolymorphismGenetic VariationGenomeGenomic SegmentGenotypeGeographic DistributionGeographic LocationsGeographyGoalsHLA AntigensHaplotypesHealthHigh-Throughput Nucleotide SequencingHistocompatibility Antigens Class IHumanHuman GenomeImmuneImmune responseImmune systemImmunityImmunogeneticsImmunoglobulinsImmunotherapyIndividualIndonesiaInfectionInflammationInvestigationKiller CellsKnowledgeLaboratoriesLifeLigandsLinkMHC Class I GenesMalignant NeoplasmsMapsMediatingMethodsModelingMorbidity - disease rateNative-BornNatural Killer CellsNatural SelectionsNatureOceaniaOrgan DonorOutcomePacific IslandsPatternPhenotypePopulationPredispositionPregnancyPropertyRegistriesResearchResolutionRoleSeverity of illnessShapesSignal TransductionSoutheastern AsiaSpecificitySyndromeTestingTissuesTrainingTreatment EfficacyUnderrepresented PopulationsVariantWorkanalytical toolbioinformatics pipelinecancer riskcombinatorialdesignexperimental studyfetalgenetic variantimplantationinnovationmortalitymulti-ethnicneglectnervous system disordernovelnovel strategiespathogenpathogen exposurepersonalized medicinepressurereceptorreproductiveresponsestudy populationtargeted sequencingtraittumorwhole genome
项目摘要
ABSTRACT
Human leukocyte antigens (HLA) and killer cell immunoglobulin-like receptors (KIR) are critical facets of the
human immune system. Interactions of KIR, expressed by natural killer cells (NK cells), with HLA class I,
expressed by most tissue cells, modulate immune cell functions. Variations in the highly polymorphic KIR and
HLA genes are linked directly to NK cell functions and have profound impact on human health, including
associations with autoimmunity and neurological disease, severity of infectious disease, pregnancy
syndromes, and risk of cancer. Our ability to resolve the mechanisms of immune-mediated disease, to develop
personalized medicines, including immunotherapies, and to match organ donors with recipients relies on our
ability to accurately characterize KIR and HLA class I diversity. Despite this crucial importance, there is a lack
of knowledge concerning the extent and nature of KIR and HLA class I diversity worldwide. This deficit includes
the Eastern Hemisphere, which encompasses half the world's population, and multiple underrepresented
groups in the USA. During this project we will fill these gaps in this knowledge through determining the
characteristics and functional consequences of KIR and HLA class I diversity across the entire Eastern
Hemisphere.
We will examine 15,612 individuals representing 51 discrete populations, including indigenous populations
from East Asia, South Asia, multiple Pacific Islands and Oceania. To overcome difficulties in analyzing these
complex genomic regions, we developed a targeted sequencing and bioinformatics approach to analyze KIR
and HLA class I genes at high throughput and resolution. To analyze an additional 22,905 individuals, we will
develop an imputation algorithm to determine high-resolution KIR alleles from whole-genome SNP data. We
will construct imputation panels specifically for these populations who have been neglected in previous
analyses. This goal will be made possible through the extensive training data generated. We will then
characterize the distribution of KIR and HLA haplotypes across the Eastern Hemisphere.
We will examine how the geographic patterns of KIR and HLA diversity have been shaped by natural selection
and investigate the impact of adaptive introgression and admixture specifically focused to the KIR and HLA loci
in our study populations. We will determine the functional properties of those variants we have identified as
targeted by natural selection. We will pursue these aims implementing innovative laboratory and analytical
tools. These developments include CRISPR/cas9 targeting of long-read sequencing to examine KIR structural
diversity, and methods both to identify alleles subject to natural selection, and the mode of selection acting on
them. The expected outcome of this work is the genetic and functional characterization of HLA and KIR across
multiple human populations, and a comprehensive understanding of how this variation is geographically
distributed and shaped by natural selection. This work will benefit investigations of immune-mediated and
infectious disease and in establishment of personalized treatments for individuals both in the USA and
worldwide.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul John Norman其他文献
Paul John Norman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul John Norman', 18)}}的其他基金
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere
东半球免疫遗传多样性的演变和功能
- 批准号:
10663162 - 财政年份:2022
- 资助金额:
$ 79.45万 - 项目类别:
Natural Killer cells and the Immunogenetics of COVID-19
自然杀伤细胞和 COVID-19 的免疫遗传学
- 批准号:
10686171 - 财政年份:2021
- 资助金额:
$ 79.45万 - 项目类别:
Natural Killer cells and the Immunogenetics of COVID-19
自然杀伤细胞和 COVID-19 的免疫遗传学
- 批准号:
10477389 - 财政年份:2021
- 资助金额:
$ 79.45万 - 项目类别:
Natural Killer cells and the Immunogenetics of COVID-19
自然杀伤细胞和 COVID-19 的免疫遗传学
- 批准号:
10297139 - 财政年份:2021
- 资助金额:
$ 79.45万 - 项目类别:
Control of Cytotoxic Lymphocytes by Polymorphic KIR3DL3
多态性 KIR3DL3 控制细胞毒性淋巴细胞
- 批准号:
10469872 - 财政年份:2021
- 资助金额:
$ 79.45万 - 项目类别:
Insights Into Immune-Related Diseases Born from Population Genomics
对群体基因组学产生的免疫相关疾病的见解
- 批准号:
10449317 - 财政年份:2010
- 资助金额:
$ 79.45万 - 项目类别:
Insights Into Immune-Related Diseases Born from Population Genomics
对群体基因组学产生的免疫相关疾病的见解
- 批准号:
10656300 - 财政年份:2010
- 资助金额:
$ 79.45万 - 项目类别:
Insights Into Immune-Related Diseases Born from Population Genomics
对群体基因组学产生的免疫相关疾病的见解
- 批准号:
10208683 - 财政年份:2010
- 资助金额:
$ 79.45万 - 项目类别:
相似海外基金
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
- 批准号:
10818088 - 财政年份:2023
- 资助金额:
$ 79.45万 - 项目类别:
Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers in African Americans
非裔美国人冠心病和相关代谢组标记物的混合图谱
- 批准号:
10571022 - 财政年份:2023
- 资助金额:
$ 79.45万 - 项目类别:
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
- 批准号:
10590405 - 财政年份:2023
- 资助金额:
$ 79.45万 - 项目类别:
NSF Postdoctoral Fellowship in Biology: Coalescent Modeling of Sex Chromosome Evolution with Gene Flow and Analysis of Sexed-versus-Gendered Effects in Human Admixture
NSF 生物学博士后奖学金:性染色体进化与基因流的合并模型以及人类混合中性别与性别效应的分析
- 批准号:
2305910 - 财政年份:2023
- 资助金额:
$ 79.45万 - 项目类别:
Fellowship Award
Admixture mapping of mosaic copy number alterations for identification of cancer drivers
用于识别癌症驱动因素的马赛克拷贝数改变的混合图谱
- 批准号:
10608931 - 财政年份:2022
- 资助金额:
$ 79.45万 - 项目类别:
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients
利用微生物组、局部混合物和机器学习来优化医疗服务不足的患者的抗凝药物基因组学
- 批准号:
10656719 - 财政年份:2022
- 资助金额:
$ 79.45万 - 项目类别:
Genealogical ancestors, admixture, and population history
家谱祖先、混合和人口历史
- 批准号:
2116322 - 财政年份:2021
- 资助金额:
$ 79.45万 - 项目类别:
Standard Grant
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
- 批准号:
10307040 - 财政年份:2021
- 资助金额:
$ 79.45万 - 项目类别:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
非裔美国儿童急性淋巴细胞白血病的混合分析:ADMIRAL 研究
- 批准号:
10307680 - 财政年份:2021
- 资助金额:
$ 79.45万 - 项目类别:














{{item.name}}会员




